New York – October 12, 2026 -- New York Blood Center Enterprises (NYBCe) has appointed Meghan Delaney, DO, MPH, as President and Chief Executive Officer, effective January 4, 2027, ending Christopher D. Hillyer's 17-year tenure atop the nonprofit blood and life sciences group.

The Board of Trustees selected Delaney following an extensive national search. Hillyer, who has led NYBCe since 2009, will become Special Advisor to the Board of Trustees. He will work with Delaney on the transition and continue to provide strategic guidance to the Board and leadership.

Los Angeles – October 12, 2026 -- R&S Holdings, a Maryland-based behavioral health organization, has acquired Innovo Detox, a Pennsylvania provider of substance use disorder (SUD) treatment and drug and alcohol rehabilitation services, in a transaction advised by M&A Healthcare Advisors (MAHA). Financial terms were not disclosed.

Burlington – October 12, 2026 -- Eighty-six percent of 21 heart failure patients at imminent risk of hospital admission were decongested at home without hospitalization using SQ Innovation's subcutaneous furosemide product Lasix ONYU, according to interim results from the investigator-sponsored Gator SCALES-WHF study.

Three patients were admitted within 30 days for additional treatment. The data were presented on October 11 at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2026 in Phoenix, Arizona.

Pittsburgh – October 12, 2026 -- STERIS, a roughly $6 billion-revenue infection prevention provider with 18,000 Associates, has agreed to acquire Pittsburgh-area surgical safety specialist Xodus Medical, adding a portfolio of operating room consumables.

Financial terms were not disclosed in the announcement.

Menlo Park – October 12, 2026 -- Endovascular Engineering, Inc. (E2) has received U.S. FDA 510(k) clearance for both the Hēlo Thrombectomy System and Hēlo Return, a blood return system the company describes as the first cleared for use with continuous vacuum aspiration.

St. Louis – October 12, 2026 -- Labrador Retrievers kept lean from puppyhood lived a median of 1.8 years longer than heavier matched littermates, according to findings from the 14-year Purina Life Span Study, which the Purina Institute is revisiting on the study's 25th anniversary.

Fargo – October 12, 2026 -- Sharp Biomedical, a medical device company building manual procedures for outpatient pain clinics, has closed its pre-seed funding round, led by North Dakota venture fund gener8tor 1889 with participation from several physician angel investors. The announcement did not disclose the round size.

Chicago – October 12, 2026 -- The American Osteopathic Foundation (AOF) has named Peter B. Ajluni, DO, an orthopedic surgeon with more than 50 years of practice, as recipient of its 2026 Lifetime Achievement Award, one of the foundation's highest honors.

The award will be presented on Friday, Oct. 23, at the AOF Honors Gala, held in conjunction with the American Osteopathic Association's (AOA) annual OMED conference. The foundation established the award in 2006 to recognize leaders whose service embodies the values of the osteopathic profession.

Los Angeles – October 12, 2026 -- TED patients with pre-existing hearing loss were more than 60% less likely to suffer a further hearing decline when teprotumumab (TEPEZZA) infusions were spaced six weeks apart instead of the standard three, according to a retrospective study presented at the ASOPRS 57th Annual Fall Scientific Symposium.

San Diego – October 12, 2026 -- Robles BioCeutics, a regenerative dermatology company built on stem cell and senolytic technologies, has appointed trial attorney Mark Skeels to its Advisory Board, adding more than 25 years of litigation, government and business-negotiation experience as it targets international expansion.